Peri-Implant Hard and Soft Tissue Changes After Immediate Implant Placement With Socket Shield and Immediate Restoration Versus Early Implant Placement in the Esthetic Zone
Evaluation of Peri-implant Hard And Soft Tissues Changes Between Immediate Implant Placement With Socket Shield Technique and Immediate Restoration Versus Early Type II Implant Placement in The Esthetic Zone - A Randomized Controlled Clinical Trial
1 other identifier
interventional
42
1 country
1
Brief Summary
This randomized controlled clinical trial aims to compare peri-implant hard and soft tissue dimensional changes following immediate implant placement with the socket shield technique and immediate restoration versus early type II implant placement with contour graft in the esthetic zone. The primary outcome is the Pink Esthetic Score (PES), while secondary outcomes include mid-facial mucosal recession, radiographic vertical and horizontal buccal bone remodeling, and patient satisfaction after 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 13, 2026
CompletedStudy Start
First participant enrolled
March 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 30, 2027
March 13, 2026
March 1, 2026
1.2 years
March 9, 2026
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pink Esthetic Score (PES)
Evaluation of peri-implant soft tissue esthetic outcome using the Pink Esthetic Score, which assesses seven parameters including mesial papilla, distal papilla, soft tissue level, soft tissue contour, alveolar process deficiency, soft tissue color, and texture around the implant restoration. Each parameter is scored from 0 to 2, with a maximum score of 14 indicating optimal esthetic outcome.
12 months after implant restoration
Secondary Outcomes (4)
Peri-implant Mid-facial Mucosal Recession
12 months after implant placement
Horizontal Radiographic Peri-implant Bone Changes
12 months after implant Restoration
Vertical Radiographic Peri-implant Bone Changes
12 months after implant Restoration
Patient Satisfaction
12 months after implant restoration
Study Arms (2)
Immediate Implant Placement and Immediate Restoration with the Socket Shield Tech
EXPERIMENTALParticipants allocated to this experimental group will undergo immediate implant placement following partial extraction therapy using the socket shield technique. After decoronation and preparation of the buccal root fragment, the implant osteotomy will be created palatal to the retained root fragment to achieve correct prosthetic positioning. The gap between the implant and the root fragment will be filled with deproteinized bovine bone mineral, and an immediate provisional restoration will be placed using a PMMA temporary crown. Final implant-supported restoration will be delivered after approximately 3 months. Participants will be followed for 12 months to evaluate peri-implant hard and soft tissue changes and esthetic outcomes.
Early Type II Implant placement with Contour augmentation with Xenograft
ACTIVE COMPARATORParticipants assigned to this active comparator group will undergo atraumatic extraction of the non-restorable tooth followed by early type II implant placement after a healing period of approximately 4-8 weeks. During implant surgery, a full-thickness flap will be elevated and the implant will be placed in the ideal prosthetic position. Contour augmentation will be performed using autogenous bone chips and deproteinized bovine bone mineral particles, which will be covered with a collagen membrane. After approximately 3 months of healing, the implant will be restored with a definitive implant-supported prosthetic restoration. Participants will be followed for 12 months to assess peri-implant hard and soft tissue changes and esthetic outcomes.
Interventions
mmediate implant placement following partial extraction therapy using the socket shield technique. After decoronation and preparation of the buccal root fragment, the implant osteotomy will be created palatal to the retained root fragment to achieve correct prosthetic positioning. The gap between the implant and the root fragment will be filled with deproteinized bovine bone mineral, and an immediate provisional restoration will be placed using a PMMA temporary crown. Final implant-supported restoration will be delivered after approximately 3 months
atraumatic extraction of the non-restorable tooth followed by early type II implant placement after a healing period of approximately 4-8 weeks. During implant surgery, a full-thickness flap will be elevated and the implant will be placed in the ideal prosthetic position. Contour augmentation will be performed using autogenous bone chips and deproteinized bovine bone mineral particles, which will be covered with a collagen membrane. After approximately 3 months of healing, the implant will be restored with a definitive implant-supported prosthetic restoration
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- Patients presenting with a single non-restorable tooth in the esthetic zone indicated for extraction and implant replacement
- Presence of a thin buccal bone plate (\<1 mm)
- Adequate bone volume to allow implant placement in a prosthetically ideal position
- Intact socket walls following tooth extraction
- Ability to achieve primary implant stability ≥35 Ncm at the time of implant placement
- Patients willing to participate in the study and able to provide written informed consent
You may not qualify if:
- History of systemic diseases that may affect bone healing
- Use of medications that may influence bone metabolism (e.g., bisphosphonates)
- Smoking within the past 5 years
- Presence of acute infection at the surgical site or adjacent teeth
- Teeth with vertical or subcrestal horizontal root fractures on the buccal aspect
- Presence of internal or external root resorption
- Severe periodontal destruction at the implant site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulf Medical University
Ajman, 4184, United Arab Emirates
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mohamed Atef Sayed, Ph.D.
Assistant Professor of Periodontics
- PRINCIPAL INVESTIGATOR
Moheb Silwadi, M.D.S
Gulf Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The present study is a single-blinded randomized clinical trial. Due to the nature of the surgical interventions, neither the operator performing the procedure nor the participants can be blinded to the treatment allocation. However, the outcome assessor responsible for evaluating the clinical photographs, digital scans, and radiographic measurements will be blinded to group allocation. In addition, the statistician performing the data analysis will also be blinded to the treatment groups to minimize assessment bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2026
First Posted
March 13, 2026
Study Start
March 30, 2026
Primary Completion (Estimated)
May 30, 2027
Study Completion (Estimated)
May 30, 2027
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share